131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes. - Wikidata - wikimedia - TriplyDB

131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

http://www.wikidata.org/entity/Q41103159

about

Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy 131I MIBG therapy in neuroblastoma: mechanisms, rationale, and current status Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy Targeted radiotherapy for neuroblastoma The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia.Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters.Transfectant mosaic spheroids: a new model for evaluation of tumour cell killing in targeted radiotherapy and experimental gene therapy.A gene therapy/targeted radiotherapy strategy for radiation cell kill by.A gene therapy approach to enhance the targeted radiotherapy of neuroblastoma.Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.Dosimetry study of [I-131] and [I-125]- meta-iodobenz guanidine in a simulating model for neuroblastoma metastasis.Modeling combined radiopharmaceutical therapy: a linear optimization framework.Multi-size spheroid formation using microfluidic funnels.Multicellular spheroids as an in vitro model in experimental oncology: applications in translational medicine.

P2860

Q26826863-B7724A3B-22E7-4603-9569-4FA2B707DDBE Q33652433-0A26CBB5-44CB-48A9-8200-FB7F8D83D57C Q34543646-54C2F4CA-295F-43C4-98EF-E540E821D76A Q35257440-321326B6-BB59-494D-BC40-561A90672D9B Q35977687-766E826C-363A-4D81-8022-27A9807E0FBE Q36291813-A04D0415-F780-4191-A732-2874750036C4 Q37078231-F8D8C1D6-3E69-411B-A5B2-B30AE02B1B9B Q38559192-18251B3C-32FF-497D-85C4-8766EEF22E74 Q40705069-8178DF24-6FD7-4316-8BF2-D387D74F7F98 Q40810551-EE483966-2AA4-4EF3-B245-0154C902C8F1 Q40838775-D7F86B4A-8A57-4E99-B4A2-67724521D068 Q41029352-240DCF36-2DA1-43FC-B0D7-A0323DFA7725 Q43747302-8F013616-B357-48A2-83AB-F02D1F14C556 Q46149964-FCDDA12E-714F-42CC-BBAA-D483B9518EA9 Q47174692-27A2D2CD-2CF2-47C1-9032-3147348393AD Q53585874-7DAE8A0C-0C59-449A-BFCE-DA1B5376BA80

P2860

131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

http://www.wikidata.org/entity/Q41103159

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

@en

type

label

131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

@en

prefLabel

131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

@en

P1433

Q41103159-1892358A-98CA-42BB-B803-1AA3F70A8DC9

P1476

Q41103159-DD3567D4-CE3F-4D61-AA2D-37D2D353B647

P2093

Q41103159-00FFDC65-452F-4E91-A80C-02D7876087D4

Q41103159-4E4DD441-E749-4E8F-9E17-DE01DB434D9F

Q41103159-53261A6F-D9A6-461D-963C-967912F0D9C5

Q41103159-63E2FB78-E126-4686-9C24-89A2B58C983A

Q41103159-8012C1EA-B7A9-45E3-9C32-5B0EAF4B6CBE

P2860

Q41103159-00088403-F5CB-4938-94D2-AED9B194C65C

Q41103159-05718D26-796C-4B78-8CC9-F945CB436E45

Q41103159-0966A690-F9F8-40B2-B3F7-9D8089889C92

Q41103159-09C9CD0C-1031-42FD-8560-BFFDE649593D

Q41103159-14E76AAF-13AF-4710-9FB1-5A52D15725C4

Q41103159-204A96DB-03D4-41DF-AEE6-74198EA12119

Q41103159-28299BA4-1FC4-41DA-873D-1F5B36CC425F

Q41103159-2DDF2875-8993-41D9-AD32-F42D2D2D6301

Q41103159-504D354F-EBE0-47F8-A71A-99EE731654C3

Q41103159-54342641-4056-49EB-970D-CB66997F228F

P2888

Q41103159-0F5074C1-CAC8-459F-9D01-9896BE97725B

P304

Q41103159-1520AD33-332B-4D31-89FC-2BC56DE62D5B

P31

Q41103159-E6D0BBA9-FADA-48CB-9FCE-D860421DA6F0

P356

Q41103159-C644AF85-E089-4D87-9205-3DA016B21D06

P407

Q41103159-01C39F54-8D51-48A2-8FF1-7D12BC662263

P433

Q41103159-666109F2-865B-4A46-9ECD-EC369BA1DCD1

P478

Q41103159-E03B5CBA-0F7D-418D-828A-A0BA26B70A61

P577

Q41103159-9EA90F4F-BB4E-4498-B590-9C68487EBA07

P5875

Q41103159-6969ADFB-39F5-4B67-8159-4547B97911E4

P6179

Q41103159-C25EB8F5-DAFD-4218-990B-F93D2924B817

P698

Q41103159-31CBEBEF-20BA-4E26-ACF6-76D6520BEF34

P932

Q41103159-A32AD051-7CD1-4747-A6D1-47B84CE81E0E

P356

P1433

British Journal of Cancer

P1476

131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

@en

P2093

Barrett A

http://www.w3.org/2001/XMLSchema#string

Boyack SM

http://www.w3.org/2001/XMLSchema#string

Gaze MN

http://www.w3.org/2001/XMLSchema#string

Mairs RJ

http://www.w3.org/2001/XMLSchema#string

Wheldon TE

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones

Radiosensitivity of different human tumor cells lines grown as multicellular spheroids determined from growth curves and survival data.

A phase I/II study of 131I mIBG in chemo-resistant neuroblastoma. The United Kingdom Children's Cancer Study Group (UKCCSG).

The distribution of alternative agents for targeted radiotherapy within human neuroblastoma spheroids

Relation of growth delay to cure for experimental tumour systems conforming to Poisson cure statistics

Growth delay in small EMT6 spheroids induced by cytotoxic drugs and its modification by misonidazole pretreatment under hypoxic conditions.

Deriving cell survival curves from the overall responses of irradiated tumours: analysis of published data for tumour spheroids

The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y.

Strategies for systemic radiotherapy of micrometastases using antibody-targeted 131I.

Dosimetric aspects of radiolabeled antibodies for tumor therapy.

P2888

P304

1048-1052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1992.408

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

1992-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21699063

http://www.w3.org/2001/XMLSchema#string

P6179

1048841759

http://www.w3.org/2001/XMLSchema#string

P698

1457344

http://www.w3.org/2001/XMLSchema#string

P932

1978020

http://www.w3.org/2001/XMLSchema#string